Dr. Reddy's Labs Files 6-K Report
Ticker: RDY · Form: 6-K · Filed: Sep 19, 2025 · CIK: 1135951
Sentiment: neutral
Topics: sec-filing, 6-k, foreign-private-issuer
TL;DR
DRL filed a 6-K, confirming 20-F annual reports and providing Hyderabad HQ details.
AI Summary
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on September 19, 2025, reporting as a foreign private issuer. The filing indicates the company will file annual reports under Form 20-F. The company's principal executive office is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana, India.
Why It Matters
This filing is a routine report for foreign private issuers, providing an update on their regulatory status and reporting requirements with the SEC.
Risk Assessment
Risk Level: low — This is a standard procedural filing for a foreign private issuer and does not contain new financial or operational information that would typically impact risk.
Key Players & Entities
- Dr. Reddy's Laboratories Ltd. (company) — Filer of the 6-K report
- 8-2-337, Road No. 3, Banjara Hills Hyderabad, Telangana 500 034, India (location) — Principal executive office address
FAQ
What type of report is Dr. Reddy's Laboratories Ltd. filing?
Dr. Reddy's Laboratories Ltd. is filing a Form 6-K, which is a Report of Foreign Private Issuer.
When was this Form 6-K filed?
The Form 6-K was filed on September 19, 2025.
Does Dr. Reddy's Laboratories Ltd. file annual reports under Form 20-F or 40-F?
The filing indicates that Dr. Reddy's Laboratories Ltd. files annual reports under cover of Form 20-F.
Where is Dr. Reddy's Laboratories Ltd.'s principal executive office located?
The principal executive office is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.
What is the Commission File Number for Dr. Reddy's Laboratories Ltd.?
The Commission File Number is 1-15182.
Filing Stats: 400 words · 2 min read · ~1 pages · Grade level 16.4 · Accepted 2025-09-18 17:47:44
Filing Documents
- rdy0805_6k.htm (6-K) — 46KB
- rdy0805_ex99-1.htm (EX-99.1) — 726KB
- rdy0805_ex99-1img01.jpg (GRAPHIC) — 11KB
- rdy0805_ex99-1img02.jpg (GRAPHIC) — 7KB
- rdy0805_ex99-1img03.jpg (GRAPHIC) — 7KB
- rdy0805_ex99-1img04.jpg (GRAPHIC) — 18KB
- rdy0805_ex99-1img05.jpg (GRAPHIC) — 10KB
- rdy0805_ex99-1img06.jpg (GRAPHIC) — 12KB
- rdy0805_ex99-1img07.jpg (GRAPHIC) — 9KB
- rdy0805_ex99-1img08.jpg (GRAPHIC) — 18KB
- rdy0805_ex99-1img09.jpg (GRAPHIC) — 10KB
- rdy0805_ex99-1img10.jpg (GRAPHIC) — 13KB
- rdy0805_ex99-1img11.jpg (GRAPHIC) — 12KB
- rdy0805_ex99-1img12.jpg (GRAPHIC) — 18KB
- rdy0805_ex99-1img13.jpg (GRAPHIC) — 12KB
- rdy0805_ex99-1img14.jpg (GRAPHIC) — 17KB
- rdy0805_ex99-1img15.jpg (GRAPHIC) — 310KB
- rdy0805_ex99-1img16.jpg (GRAPHIC) — 354KB
- rdy0805_ex99-1img17.jpg (GRAPHIC) — 291KB
- rdy0805_ex99-1img18.jpg (GRAPHIC) — 301KB
- rdy0805_ex99-1img19.jpg (GRAPHIC) — 318KB
- rdy0805_ex99-1img20.jpg (GRAPHIC) — 345KB
- rdy0805_ex99-1img21.jpg (GRAPHIC) — 307KB
- rdy0805_ex99-1img22.jpg (GRAPHIC) — 312KB
- rdy0805_ex99-1img23.jpg (GRAPHIC) — 337KB
- rdy0805_ex99-1img24.jpg (GRAPHIC) — 350KB
- rdy0805_ex99-1img25.jpg (GRAPHIC) — 347KB
- 0001575872-25-000583.txt ( ) — 5935KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY'S LABORATORIES LIMITED (Registrant) Date: September 18, 2025 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3